FDA Approved: DEFLAZACORT ORAL SUSPENSION — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

The FDA approved a supplemental application to add an oral suspension formulation of deflazacort, expanding the available dosage form for Zydus Pharmaceuticals …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• DEFLAZACORT ORAL SUSPENSION (deflazacort)

Snippet

SUPPL AP for DEFLAZACORT ORAL SUSPENSION (DEFLAZACORT)